Gene “silencing” May Improve Success Of Islet Cell Transplants For Diabetes - Molecular Pharmaceutics
Nov 25th 2008Drug InformationDiabetes
Scientists in Tennessee are reporting that a gene therapy technique called “gene silencing” shows promise for improving the effectiveness and expanded use of transplants of insulin-producing cells to treat insulin-dependent, or type 1, diabetes. The study is scheduled for the December 1 issue of ACS’ Molecular Pharmaceutics, a bi-monthly journal.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
